|
|
||||||||
|
FIGURE 2. Patient with AGC and pathologically proven N1 metastasis. (A) 18F-FDG PET shows mass with increased 18F-FDG uptake in body of stomach without perigastric lymph node metastasis. (B) Perigastric lymph node (arrow) is noted on CT. Sensitivity of CT is significantly higher than that of PET for N1 disease.
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |